Cosmos Health Reports Record $54.3M Nine-Month Revenue, Reaffirms Outlook
Key Facts
Cosmos Health reported record preliminary nine-month revenue of $54.3 million for 2026, representing a 19% increase year-over-year. According to a statement via ACCESS Newswire, third-quarter revenue reached a record $17.4 million, surpassing the previous record set in 2025. The company reaffirmed its full-year 2026 revenue outlook of over $90 million, anticipating that the fourth quarter will be its strongest on record.
COSM closed at $0.3195 on October 6, 2026, with the stock trading between a low of $0.3121 and a high of $0.3529 during that session. The financial growth is driven by performance across contract manufacturing, pharmaceutical distribution, and proprietary brands, alongside accelerating sales momentum within the U.S. market.